Article
Genetic mutations in Plasmodium falciparum and Plasmodium vivax dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) in Vanuatu and Solomon Islands prior to the introduction of artemisinin combination therapy.
Malaria journal - 14 Oct 2014
Gresty Karryn J, Gray Karen-Ann, Bobogare Albino, Wini Lyndes, Taleo George, Hii Jeffrey, Cheng Qin, Waters Norman C
Abstract excerpt
BACKGROUND: Plasmodium falciparum and Plasmodium vivax are endemic in Vanuatu and the Solomon Islands. While both countries have introduced artemether-lumefantrine (AL) as first-line therapy for both P. falciparum and P. vivax since 2008, chloroquine and sulphadoxine-pyrimethamine (SP) were used as first-line therapy for many years prior to the introduction of AL. Limited data are available on the extent of SP...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.